Patent Cliff': How Pfizer has Responded to the Loss of its Best-selling Drug
Uloženo v:
| Médium: | Elektronický zdroj E-kniha |
|---|---|
| Vydáno: |
Marketline
2012
|
| On-line přístup: | Available in Business Source Ultimate. Zobrazit v on-line katalogu |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
MARC
| LEADER | 00000nam a22000002 4500 | ||
|---|---|---|---|
| 001 | ebs70735266e | ||
| 003 | EBZ | ||
| 006 | m d |||||| | ||
| 007 | cr|unu|||||||| | ||
| 008 | 251205nuuuuuuuuxx |||| o|||||||||||||||d | ||
| 035 | |a (EBZ)ebs70735266e | ||
| 040 | |a EBZ | ||
| 042 | |a msc | ||
| 050 | 0 | 0 | |a |
| 130 | 0 | |a Patent Cliff': How Pfizer has Responded to the Loss of its Best-selling Drug (Online) | |
| 245 | 0 | 0 | |a Patent Cliff': How Pfizer has Responded to the Loss of its Best-selling Drug |h [electronic resource]. |
| 260 | |b Marketline |c 2012 | ||
| 773 | 0 | |t Business Source Ultimate |d EBSCO | |
| 856 | 4 | 0 | |3 Full text available: Jun 2012. |z Available in Business Source Ultimate. |u https://biblioteca.ues.edu.sv/acceso/ebsco/?url=https%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dbsu%26jid%3DFI4B%26scope%3Dsite |
| 901 | |a Case Study | ||